Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Voting for or against Directors

<< Previous

Bullboard Posts

Next >>

Post by palinc2000on Mar 27, 2024 5:55pm

150 Views

Post# 35956690

Voting for or against Directors

Last year investors on this MB did not succedd in removing any directors because of you know who,,,
I dont think there is any chance of being successful this year but I think ehose who are not pleased with Board Members should still exercise their right to vote against all except Zwick

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec